Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products
NCT01071577 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 65
Last updated 2025-10-02
Summary
Background:
* Bone marrow stromal cells (BMSCs) can be grown from bone marrow provided by healthy volunteers. Volunteer bone marrow donors for BMSCs are generally required to meet the same healthy history and infectious disease marker screening criteria as volunteer blood donors. BMSCs are being used to treat a number of immune system and cardiovascular disorders, including graft-versus-host disease (GVHD), heart disease, and vascular disease. The National Institutes of Health Clinical Center is interested in collecting bone marrow aspirates and biopsies from healthy volunteers to produce clinical-grade BMSCs to treat Clinical Center patients.
* This study will also collect bone marrow from autologous donors (donors who will later receive their own BMSCs) for further treatment.
Objectives:
\- To collect bone marrow aspirates and biopsies from healthy subjects and autologous donors in order to produce BMSCs.
Eligibility:
\- Individuals at least 18 years of age who are either healthy volunteers or individuals who will need to receive their own BMSCs.
Design:
* Prospective healthy volunteers will be asked a series of questions designed to identify exposure to human immunodeficiency virus (HIV), hepatitis B or C, or other transfusion-transmitted diseases. A blood sample will be collected and tested for the abovementioned diseases and for other problems that may prevent bone marrow donation.
* Prospective autologous donors will also have blood tests to evaluate their own suitability for bone marrow donation.
* Eligible participants will be scheduled to provide a marrow aspirate/biopsy, taken from the upper part of the thigh bone, using standard bone marrow donation techniques.
* The collected bone marrow will be processed into BMSCs at the National Institutes of Health.
Conditions
- Bone Marrow Stromal Cells
Sponsors & Collaborators
-
National Institutes of Health Clinical Center (CC)
lead NIH
Principal Investigators
-
David F Stroncek, M.D. · National Institutes of Health Clinical Center (CC)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-17
- Primary Completion
- 2016-12-31
- Completion
- 2018-08-07
Countries
- United States
Study Locations
More Related Trials
-
Autologous Bone Marrow Stem Cell Transplantation in Patients With Subacute Spinal Cord Injury
NCT05671796 ·Status: UNKNOWN ·Phase: PHASE2
-
University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol
NCT01463475 ·Status: COMPLETED ·Phase: NA
-
Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease
NCT05362786 ·Status: COMPLETED ·Phase: PHASE1
-
Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease
NCT01522716 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI)
NCT01770613 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging
NCT01771679 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression.
NCT03059355 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Stem Cell Ophthalmology Treatment Study
NCT01920867 ·Status: UNKNOWN ·Phase: NA
-
Bone Marrow Stromal Cells for Inflammatory Bowel Diseases
NCT01851343 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia
NCT04014166 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T Therapy
NCT07212335 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Marrow Cellution™ vs. Traditional BMA Harvest Project
NCT06388993 ·Status: RECRUITING ·Phase: NA
-
Collection of Bone Marrow Aspirate From Normal Volunteers
NCT03949647 ·Status: RECRUITING
-
Treatment for Acute Spinal Cord Injury
NCT00695149 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Autologous Bone Marrow Mononuclear Cells in Patients With Severe Critical Limb Ischemia
NCT01472289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Procurement of Tissue Samples for Cell Cultures and Analyses
NCT00435877 ·Status: TERMINATED
-
BMAC & Allograft vs BMP-2
NCT02924571 ·Status: COMPLETED ·Phase: NA
-
A Study of Carbon 13-based Deep Labelling of Bone Marrow Cells
NCT07057583 ·Status: ENROLLING_BY_INVITATION
-
Induced Wound Healing by Application of Expanded Bone Marrow Stem Cells in Diabetic Patients With Critical Limb Ischemia
NCT01065337 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Collection
NCT00316069 ·Status: TERMINATED
-
Study to Assess Efficacy and Safety of Bone Marrow Derived Stem Cells in Patients With Critical Limb Ischemia
NCT01867190 ·Status: COMPLETED ·Phase: PHASE2
-
Transplantation of Autologous Bone Marrow or Leukapheresis-Derived Stem Cells for Treatment of Spinal Cord Injury
NCT02687672 ·Status: UNKNOWN ·Phase: PHASE2
-
Bone Marrow Stem Cell Infusion Following a Heart Attack
NCT00268307 ·Status: COMPLETED ·Phase: PHASE1
-
Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease
NCT02032446 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Autologous Bone Marrow Stem Cell Transfer in Patients With Chronical Critical Limb Ischemia and Diabetic Foot
NCT01232673 ·Status: COMPLETED ·Phase: PHASE2